Ocular adnexal lymphoma – A single-center observational study of survival outcomes
Purpose: This study aims to comprehensively characterize the clinical, demographic, and histopathological features of ocular adnexal lymphoma (OAL) and assess their impact on patients’ survival outcomes. Methods: A total of 123 patients were included in the study; of these, 93 patients were selected...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-02-01
|
| Series: | Indian Journal of Ophthalmology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/IJO.IJO_110_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832087273529671680 |
|---|---|
| author | Karuvel Kannan Saraswathi Pragya Saini Radhakrishnan Santhi Veerappan Muthukkaruppan Ayyasamy Vanniarajan Usha Kim |
| author_facet | Karuvel Kannan Saraswathi Pragya Saini Radhakrishnan Santhi Veerappan Muthukkaruppan Ayyasamy Vanniarajan Usha Kim |
| author_sort | Karuvel Kannan Saraswathi |
| collection | DOAJ |
| description | Purpose:
This study aims to comprehensively characterize the clinical, demographic, and histopathological features of ocular adnexal lymphoma (OAL) and assess their impact on patients’ survival outcomes.
Methods:
A total of 123 patients were included in the study; of these, 93 patients were selected for survival analysis. Survival data were analyzed using the Kaplan-Meier test, and correlation was assessed through the log-rank test and Cox regression analysis.
Results:
The median age at presentation was 56 years. Furthermore, 98% of patients had primary OAL. The orbit was the most common site of involvement. The majority of patients were of B-cell origin (98%), and only 2% of patients had T-cell lymphoma. In addition, 83% of patients were treated with chemotherapy, and with a median follow-up of 38 months, complete remission was achieved in 48% of patients. The median progression-free survival was 26.4 months. The presence of disseminated disease was strongly linked to an unfavorable prognosis (P < 0.001) and reduced survival (P = 0.037).
Conclusion:
The 5-year overall survival of the entire study cohort was 81%. The prognosis for OAL is found to be favorable, but the presence of dissemination serves as a notable predictor for poor prognosis. |
| format | Article |
| id | doaj-art-d6b640c26c004589866aea9d039ea047 |
| institution | Kabale University |
| issn | 0301-4738 1998-3689 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Indian Journal of Ophthalmology |
| spelling | doaj-art-d6b640c26c004589866aea9d039ea0472025-02-06T05:39:35ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892025-02-0173226126610.4103/IJO.IJO_110_24Ocular adnexal lymphoma – A single-center observational study of survival outcomesKaruvel Kannan SaraswathiPragya SainiRadhakrishnan SanthiVeerappan MuthukkaruppanAyyasamy VanniarajanUsha KimPurpose: This study aims to comprehensively characterize the clinical, demographic, and histopathological features of ocular adnexal lymphoma (OAL) and assess their impact on patients’ survival outcomes. Methods: A total of 123 patients were included in the study; of these, 93 patients were selected for survival analysis. Survival data were analyzed using the Kaplan-Meier test, and correlation was assessed through the log-rank test and Cox regression analysis. Results: The median age at presentation was 56 years. Furthermore, 98% of patients had primary OAL. The orbit was the most common site of involvement. The majority of patients were of B-cell origin (98%), and only 2% of patients had T-cell lymphoma. In addition, 83% of patients were treated with chemotherapy, and with a median follow-up of 38 months, complete remission was achieved in 48% of patients. The median progression-free survival was 26.4 months. The presence of disseminated disease was strongly linked to an unfavorable prognosis (P < 0.001) and reduced survival (P = 0.037). Conclusion: The 5-year overall survival of the entire study cohort was 81%. The prognosis for OAL is found to be favorable, but the presence of dissemination serves as a notable predictor for poor prognosis.https://journals.lww.com/10.4103/IJO.IJO_110_24b-cell lymphomadisease-specific survivalocular adnexal lymphomaorbital malignancyoverall survivalprogression-free survival |
| spellingShingle | Karuvel Kannan Saraswathi Pragya Saini Radhakrishnan Santhi Veerappan Muthukkaruppan Ayyasamy Vanniarajan Usha Kim Ocular adnexal lymphoma – A single-center observational study of survival outcomes Indian Journal of Ophthalmology b-cell lymphoma disease-specific survival ocular adnexal lymphoma orbital malignancy overall survival progression-free survival |
| title | Ocular adnexal lymphoma – A single-center observational study of survival outcomes |
| title_full | Ocular adnexal lymphoma – A single-center observational study of survival outcomes |
| title_fullStr | Ocular adnexal lymphoma – A single-center observational study of survival outcomes |
| title_full_unstemmed | Ocular adnexal lymphoma – A single-center observational study of survival outcomes |
| title_short | Ocular adnexal lymphoma – A single-center observational study of survival outcomes |
| title_sort | ocular adnexal lymphoma a single center observational study of survival outcomes |
| topic | b-cell lymphoma disease-specific survival ocular adnexal lymphoma orbital malignancy overall survival progression-free survival |
| url | https://journals.lww.com/10.4103/IJO.IJO_110_24 |
| work_keys_str_mv | AT karuvelkannansaraswathi ocularadnexallymphomaasinglecenterobservationalstudyofsurvivaloutcomes AT pragyasaini ocularadnexallymphomaasinglecenterobservationalstudyofsurvivaloutcomes AT radhakrishnansanthi ocularadnexallymphomaasinglecenterobservationalstudyofsurvivaloutcomes AT veerappanmuthukkaruppan ocularadnexallymphomaasinglecenterobservationalstudyofsurvivaloutcomes AT ayyasamyvanniarajan ocularadnexallymphomaasinglecenterobservationalstudyofsurvivaloutcomes AT ushakim ocularadnexallymphomaasinglecenterobservationalstudyofsurvivaloutcomes |